India’s Shift to High-Value, Innovation-Led Pharma: Spotlight on GLP-1
India’s GLP-1 market opened up almost overnight. Semaglutide came off patent in March 2026, and multiple Indian manufacturers launched generics […]
SEMAGLUTIDE-INDIA
India’s First Doctor-Led GLP-1 Ecosystem: Early.fit
For generations, obesity in India was managed the same way: with advice that placed the entire burden on the individual. […]
